Saint Georges d'Orques, France

Claude Plouzane


Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 1989-1996

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Claude Plouzane: Innovator in Pharmaceutical Chemistry

Introduction

Claude Plouzane is a notable inventor based in Saint Georges d'Orques, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on N-sulfonylindoline derivatives. With a total of 5 patents to his name, Plouzane's inventions have the potential to impact medical science significantly.

Latest Patents

One of Claude Plouzane's latest patents focuses on N-sulfonylindoline derivatives, which are characterized by their unique formulae (I) and (I)'. This invention relates to the preparation of these derivatives and their incorporation into pharmaceutical compositions. The compounds developed by Plouzane exhibit an affinity for vasopressin and oxytocin receptors, indicating their potential therapeutic applications.

Career Highlights

Throughout his career, Claude Plouzane has worked with prominent companies in the pharmaceutical industry, including Sanofi and Elf Sanofi. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Plouzane has collaborated with several notable professionals in his field, including Jean Wagnon and Dino Nisato. These partnerships have facilitated the exchange of ideas and fostered innovation in his research endeavors.

Conclusion

Claude Plouzane's work in the field of pharmaceutical chemistry exemplifies the impact of innovative thinking on medical science. His contributions through patents and collaborations continue to pave the way for advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…